277 related articles for article (PubMed ID: 19050276)
1. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.
Brien JD; Uhrlaub JL; Nikolich-Zugich J
J Immunol; 2008 Dec; 181(12):8568-75. PubMed ID: 19050276
[TBL] [Abstract][Full Text] [Related]
2. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
[TBL] [Abstract][Full Text] [Related]
3. Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.
Uhrlaub JL; Brien JD; Widman DG; Mason PW; Nikolich-Zugich J
J Immunol; 2011 Apr; 186(7):3882-91. PubMed ID: 21339368
[TBL] [Abstract][Full Text] [Related]
4. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.
Brien JD; Uhrlaub JL; Nikolich-Zugich J
Eur J Immunol; 2007 Jul; 37(7):1855-63. PubMed ID: 17559175
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
Purtha WE; Myers N; Mitaksov V; Sitati E; Connolly J; Fremont DH; Hansen TH; Diamond MS
Eur J Immunol; 2007 Jul; 37(7):1845-54. PubMed ID: 17559174
[TBL] [Abstract][Full Text] [Related]
6. Key role of T cell defects in age-related vulnerability to West Nile virus.
Brien JD; Uhrlaub JL; Hirsch A; Wiley CA; Nikolich-Zugich J
J Exp Med; 2009 Nov; 206(12):2735-45. PubMed ID: 19901080
[TBL] [Abstract][Full Text] [Related]
7. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.
Hughes HR; Crill WD; Davis BS; Chang GJ
Virology; 2012 Mar; 424(2):129-37. PubMed ID: 22244913
[TBL] [Abstract][Full Text] [Related]
8. CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.
Wang Y; Lobigs M; Lee E; Koskinen A; Müllbacher A
J Gen Virol; 2006 Dec; 87(Pt 12):3599-3609. PubMed ID: 17098975
[TBL] [Abstract][Full Text] [Related]
9. Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses.
Trobaugh DW; Yang L; Ennis FA; Green S
Eur J Immunol; 2010 May; 40(5):1315-27. PubMed ID: 20213733
[TBL] [Abstract][Full Text] [Related]
10. Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine.
Karkashan A
Front Immunol; 2024; 15():1395870. PubMed ID: 38799422
[TBL] [Abstract][Full Text] [Related]
11. A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.
Pinto AK; Richner JM; Poore EA; Patil PP; Amanna IJ; Slifka MK; Diamond MS
J Virol; 2013 Feb; 87(4):1926-36. PubMed ID: 23221549
[TBL] [Abstract][Full Text] [Related]
12. A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
Martina BE; van den Doel P; Koraka P; van Amerongen G; Spohn G; Haagmans BL; Provacia LB; Osterhaus AD; Rimmelzwaan GF
PLoS One; 2011 Apr; 6(4):e18995. PubMed ID: 21541326
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN
PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579
[TBL] [Abstract][Full Text] [Related]
14. Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
Gershoni-Yahalom O; Landes S; Kleiman-Shoval S; Ben-Nathan D; Kam M; Lachmi BE; Khinich Y; Simanov M; Samina I; Eitan A; Cohen IR; Rager-Zisman B; Porgador A
Immunology; 2010 Aug; 130(4):527-35. PubMed ID: 20331473
[TBL] [Abstract][Full Text] [Related]
15. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
Chu JH; Chiang CC; Ng ML
J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
[TBL] [Abstract][Full Text] [Related]
16. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
Sitati EM; Diamond MS
J Virol; 2006 Dec; 80(24):12060-9. PubMed ID: 17035323
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain.
Welte T; Xie G; Wicker JA; Whiteman MC; Li L; Rachamallu A; Barrett A; Wang T
Vaccine; 2011 Jun; 29(29-30):4853-61. PubMed ID: 21549792
[TBL] [Abstract][Full Text] [Related]
19. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096
[TBL] [Abstract][Full Text] [Related]
20. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
